You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Colorcon
Johnson and Johnson
McKesson
Baxter

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

Adare Pharms Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ADARE PHARMS INC, and what generic and branded alternatives to ADARE PHARMS INC drugs are available?

ADARE PHARMS INC has four approved drugs.



Summary for Adare Pharms Inc
US Patents:0
Tradenames:3
Ingredients:3
NDAs:4

Drugs and US Patents for Adare Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Adare Pharms Inc POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 076368-002 Jun 5, 2019 AB1 RX No No   Start Trial   Start Trial
Adare Pharms Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 210279-005 Oct 9, 2018 AB RX No No   Start Trial   Start Trial
Adare Pharms Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 210279-002 Oct 9, 2018 AB RX No No   Start Trial   Start Trial
Adare Pharms Inc POTASSIUM CHLORIDE potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 208864-002 Mar 17, 2017 AB RX No No   Start Trial   Start Trial
Adare Pharms Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 210279-003 Oct 9, 2018 AB RX No No   Start Trial   Start Trial
Adare Pharms Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 210279-007 Oct 9, 2018 AB RX No No   Start Trial   Start Trial
Adare Pharms Inc PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078703-003 Jul 15, 2011 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Merck
Moodys
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.